tm logo

Monitor this mark

View On USPTO

REVLIMID
Live/Registered
REGISTERED AND RENEWED

on 12 Jun 2024

Last Applicant/ Owned by

Celgene Corporation

86 Morris Avenue

Summit

NJ

07901

Serial Number

78188450 filed on 25th Nov 2002

Registration Number

2925808 registered on 08th Feb 2005

in the Principal Register

Correspondent Address

Marilyn F. Kelly

Marilyn F. Kelly Bristol-Myers Squibb Company

Trademark Dept., Mailstop D.4243

PRINCETON, NJ 08648

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

REVLIMID

pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classification Information

Class [005]
Pharmaceutical Products

pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

First Use Date in General

19th Feb 2004

First Use Date in Commerce

03rd Jun 2004

Mark Details

Serial Number

No 78188450

Mark Type

No Service/Collective Mark

Attorney Docket Number

No CELG0334US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
12th Jun 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12th Jun 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12th Jun 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
31st May 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22nd Feb 2024TEAS SECTION 8 & 9 RECEIVED
08th Feb 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09th Dec 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09th Dec 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09th Dec 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Dec 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED